Biotech Stocks Icon

Biotech Stocks

Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.

Recent Biotech Stocks Articles

7 Biotech Stocks to Sell in July

Running the gamut from large to small, and from commercial stage to clinical stage, these are seven top biotech stocks to sell in July.

3 Biotech Stocks to Sell Before They Damage Your Portfolio 

With the Street generally bearish towards the biotech sector, investors need to identify biotech stocks to avoid at this point. 

RXRX Stock: Nvidia Investment Sends Recursion Pharmaceuticals Soaring

Nvidia just invested millions into Recursion Pharmaceuticals, bolstering AI integration in biotech but also presenting risks for RXRX stock.

3 Hypergrowth Stocks to Catapult You into the Millionaires’ Club

Which growth stocks can put you in the millionaires' club sooner? These three hypergrowth stocks can make great additions to your portfolio.

3 Biotech Stocks That AI is Loving in July

As AI becomes a more entrenched aspect of society, investors can lean on these AI recommended biotech stocks with predicted high potential.

Why These 7 Stocks Are the Best Ways to Play Biotech Right Now

With biotech stocks offering myriad viable opportunities irrespective of broader conditions, this sector is worth a closer look.

DNA Stock Alert: Ginkgo Bioworks Moves Forward With Novo Nordisk Partnership

Ginkgo Bioworks (DNA) stock is on the move Tuesday after the company announced a continued partnership with Novo Nordisk.

Why Is Better Therapeutics (BTTX) Stock Up 39% Today?

Better Therapeutics (BTTX) stock is taking off on Tuesday as investors react to approval from the FDA for a Type 2 diabetes treatment.

Why Is CytoMed Therapeutics (GDTC) Stock Up 157% Today?

CytoMed Therapeutics (GDTC) stock is rocketing higher on Tuesday despite a lack of news concerning the company this morning.

Time to Evolve: 3 Synthetic Biology Stocks to Sell Off Now

The biotech boom has become a biotech bust. Many companies still have further to fall, so sell these three before they hit rock bottom.

Looking for Biotech AI Stocks? 3 Names That Will Benefit From the AI Boom

AI is changing the face of biotechnology and drug discovery. Don't miss out on the next big boom in biotech, here are 3 stocks to consider.

BIIB Stock Alert: What to Know as FDA Approves Biogen’s Alzheimer’s Drug

Biogen (BIIB) stock is in the news Friday after the pharmaceutical company got approval from the FDA for its Alzheimer's drug.

3 Biotech Stocks to Make Your ‘Get Rich’ Dreams Come True

These high return biotech stocks offer tremendous upside ahead and are likely to soar on the back of several growth drivers

The $25 Million Reason Caribou Biosciences (CRBU) Stock Is Soaring Today

Caribou Biosciences (CRBU) stock is taking off on Thursday after the gene-editing company announced an investment from Pfizer (PFE).

Why Is Nymox Pharmaceutical (NYMX) Stock Down 18% Today?

Nymox Pharmaceutical (NYMX) stock is falling on Thursday after the company told investors its shares will be delisted tomorrow.

Why Is VBI Vaccines (VBIV) Stock Down 40% Today?

VBI Vaccines (VBIV) stock is taking a beating on Thursday after the pharmaceutical company announced two stock offerings.

3 Biotech Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2025

In researching this article, we used AI to help make predictions for potential triple-digit return biotech stocks by 2025

Cassava Sciences (SAVA) Stock Drops Despite Positive Trial Results

Cassava Sciences (SAVA) stock is down 11% on underwhelming results from its clinical trials for its Alzheimer's treatment.

Why Is Allarity Therapeutics (ALLR) Stock Up 30% Today?

Allarity Therapeutics became the toast of Wall Street Wednesday with positive early clinical data, though ALLR stock remains risky.